Crinetics Pharmaceuticals, Inc. (CRNX)

CIK 1658247 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Crinetics Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 202615-12G0001140361-26-036281
Sep 1, 202640001628280-26-059904
Sep 1, 2026S-8 POS0001140361-26-035257
Sep 1, 202640001628280-26-059901
Sep 1, 202640001628280-26-059910
Sep 1, 2026S-8 POS0001140361-26-035253
Sep 1, 2026S-8 POS0001140361-26-035251
Sep 1, 202640001628280-26-059883
Sep 1, 202640001628280-26-059905
Sep 1, 202640001628280-26-059884
Sep 1, 2026S-8 POS0001140361-26-035250
Sep 1, 2026S-8 POS0001140361-26-035256
Sep 1, 2026POSASR0001140361-26-035229
Sep 1, 202625-NSE0001354457-26-000839
Sep 1, 202640001628280-26-059885
Sep 1, 2026S-8 POS0001140361-26-035254
Sep 1, 2026S-8 POS0001140361-26-035255
Sep 1, 2026S-8 POS0001140361-26-035252
Sep 1, 202640001628280-26-059902
Sep 1, 202640001628280-26-059900
Sep 1, 202640001628280-26-059907
Sep 1, 2026S-8 POS0001140361-26-035249
Sep 1, 2026POSASR0001140361-26-035224
Sep 1, 20268-K0001140361-26-035195
Sep 1, 202640001628280-26-059882